Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Genfit
Genfit
Genfit bags FDA breakthrough tag on route to phase 3 in PBC
Fierce Biotech
Thu, 04/18/19 - 10:21 am
Genfit
FDA
primary biliary cholangitis
elafibranor
clinical trials
Upcoming events – a legal verdict for Enbrel and a clinical one for Cymabay
EP Vantage
Sat, 04/13/19 - 12:23 pm
Amgen
Enbrel
CymaBay
NASH
Erelzi
seladelpar
Genfit
March Madness: "The Fabulous 5" Life Science IPOs
BioSpace
Wed, 03/27/19 - 11:49 am
IPOs
Genfit
Silk Road Medical
NGM Biopharmaceuticals
Precision Biosciences
Shockwave Medical
GenFit gets $135M Nasdaq IPO for NASH, PBC hopes
Fierce Biotech
Wed, 03/27/19 - 10:21 am
Genfit
IPOs
NASH
primary biliary cholangitis
GENFIT Seeks $132 Million IPO to Support NASH Programs
BioSpace
Fri, 03/15/19 - 10:49 am
Genfit
IPOs
NASH
Genfit files for NASDAQ listing
BioCentury
Thu, 02/28/19 - 09:58 am
Genfit
NASH
NASDAQ
While we wait for NASH data, Genfit reports positive elafibranor data in PBC patients
Endpoints
Thu, 12/6/18 - 10:02 am
Genfit
NASH
Gilead Sciences
Intercept Pharma
clinical trials
elafibranor
Genfit plans US listing as NASH drugmakers race to the finish line
Endpoints
Mon, 11/19/18 - 11:44 pm
Genfit
IPOs
NASH
NASH drugs come into focus as field awaits late-stage data
BioSpace
Sat, 11/10/18 - 12:43 pm
NASH
Intercept Pharma
Gilead Sciences
Genfit
Allergan
GENFIT Receives Positive Safety Review for NASH Candidate Elafibranor
CP Wire
Mon, 04/23/18 - 10:35 pm
Genfit
NASH
elafibranor
GENFIT Receives Positive Safety Review for NASH Candidate Elafibranor
Mon, 04/23/18 - 10:00 am
Genfit
Could These 2 Small Biotechs Beat Allergan and Gilead Sciences?
Motley Fool
Sat, 12/17/16 - 12:23 pm
biotech
Allergan
Gilead Sciences
Genfit
Intercept Pharmaceuticals
NASH
Who Is Gilead Going To Buy?
Seeking Alpha
Mon, 03/7/16 - 10:07 pm
Gilead Sciences
M&A
Genfit
Intercept Pharma
Agios Pharmaceuticals
Ziopharm
Genfit to conduct large liver drug trial despite setback
Yahoo/Reuters
Thu, 03/26/15 - 09:27 pm
Genfit
NASH
GFT-505
4 Biotech Reports This Month That Could Move Stocks
Investors.com
Thu, 03/19/15 - 08:15 am
Biogen Idec
BIIB037
Genfit
NASH
GFT-505
Vertex Pharmaceuticals
VX-661
Merck
grazoprevir
Genfit's Fatty Liver Drug Study Results Are Coming. Here's What You Need to Know.
TheStreet.com
Thu, 03/12/15 - 07:53 am
Genfit
NASH
GFT505
Genfit is next up in the M&A rumor mill thanks to its NASH drug
Fierce Biotech
Wed, 03/4/15 - 10:12 am
Genfit
M&A
NASH
GFT505
Biotech stocks to watch ahead of liver disease conference
CNBC
Fri, 11/7/14 - 03:54 pm
liver disease
Gilead Sciences
Intercept Pharma
Genfit
Merck
Achillion
AbbVie
NASH
hepatitis B
hepatitis C
The next hepatitis C? NASH
CNBC
Tue, 07/15/14 - 09:48 am
NASH
hepatitis C
liver disease
nonalcoholic steatohepatitis
Genfit
Gilead Sciences
Intercept Pharma
GENFIT's drug candidate GFT505 gets patent protection from major countries
Pharmabiz
Sat, 02/25/12 - 10:02 am
Genfit
GFT505
diabetes
Pages
« first
‹ previous
1
2
3
next ›
last »